Virax Biolabs Group Ltd. is a holding company, which engages in the sale, distribution, and marketing of diagnostics test kits and med-tech and personal protective equipment products for the prevention, detection, diagnosis, and risk management of viral diseases with a particular interest in the field of immunology. The company was founded by James Foster and Cameron Shaw in 2013 and is headquartered in London, the United Kingdom.
Sector:
Finance
Industry:
Financial Conglomerates
Employees:
26
Frequently Asked Questions
Market cap, also known as market capitalization, is the total market value of a company. It's calculated by multiplying the current market price by the total number of shares outstanding. Virax Biolabs Group Ltd - Ordinary Shares - Class A market cap is $598,654.00.
52 week high is the highest price of a stock in the past 52 weeks, or one year. Virax Biolabs Group Ltd - Ordinary Shares - Class A 52 week high is $21.75 as of November 18, 2026.
52 week low is the lowest price of a stock in the past 52 weeks, or one year. Virax Biolabs Group Ltd - Ordinary Shares - Class A 52 week low is $0.4004 as of November 18, 2026.
Virax Biolabs Group Ltd - Ordinary Shares - Class A stock price today is $0.43.
Virax Biolabs Group Ltd - Ordinary Shares - Class A stock price yesterday was $0.4451.
The Price-to-Earnings (or P/E) ratio is a commonly used tool for valuing a company. It's calculated by dividing the current share price by the earnings per share (or EPS). It can also be calculated by dividing the company's Market Cap by the Net Profit. Virax Biolabs Group Ltd - Ordinary Shares - Class A's P/E ratio is -0.03.
The Price-to-Book (P/B) ratio is a commonly used tool for valuing a company. It's calculated by dividing a company's market capitalization by its book value. Virax Biolabs Group Ltd - Ordinary Shares - Class A P/B ratio is 0.034.
The 50-day moving average is a frequently used data point by active investors and traders to understand the trend of a stock. It's calculated by averaging the closing stock price over the previous 50 trading days. Virax Biolabs Group Ltd - Ordinary Shares - Class A 50-day moving average is $1.70.
Virax Biolabs Group Ltd - Ordinary Shares - Class A has 26 employees.